Flora Peyvandi: Key Guidance from ISTH on Pediatric Antithrombotic Therapies
Flora Peyvandi, Professor of Internal Medicine at the University of Milan and former President of ISTH, shared a post on X about a recent article by Neil A. Goldenberg et al, adding:
“Development of New Antithrombotic Drugs for Children (Part 1): Guidance from the ISTH SSC Subcommittee on Pediatric and Neonatal Thrombosis and Hemostasis and the Pedi-ATLAS Group – Journal of Thrombosis and Haemostasis.”
Title: Development of New Antithrombotic Drugs for Children (Part 1): Guidance from the ISTH SSC Subcommittee on Pediatric and Neonatal Thrombosis and Hemostasis and the Pedi-ATLAS Group
Authors: Neil A. Goldenberg, Scott D. Berkowitz, Marisol Betensky, Susanne Holzhauer, Vera Ignjatovic, Amy Kiskaddon, Daniel Schaufelberger, Paul Monagle, Christoph Male
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 2, 2026, 15:28Kabilan K. L.: Management and Diagnosis of Acute Coronary Syndrome Types
-
Jun 2, 2026, 15:26Mital Jhaveri: What New Data Reveal About DOACs and Androgen Receptor Inhibitors?
-
Jun 2, 2026, 15:22Dhananjaya Kotebagilu Narayana Vamyanmane: High-Resolution Ultrasound Evaluation of Bowel Wall Ischemia
-
Jun 2, 2026, 15:20Joep Schellens: Influence of Dexamethasone and Tocilizumab on Fibrinolysis in COVID-19
-
Jun 2, 2026, 15:12Ebrahim Umer: The Sickest Liver Patients Deserve One Language – Lessons from the Kyoto Consensus
-
Jun 2, 2026, 15:10Ney Carter Borges: Bempedoic Acid and Venous Thromboembolism Risk in Statin-Intolerant Patients
-
Jun 2, 2026, 15:07Sayan Koley: Coagulation Science – Where Precision Saves Lives
-
Jun 2, 2026, 15:04Ahmed Mohsen: Low CHA₂DS₂-VA Score Does Not Always Mean No Anticoagulation
-
Jun 2, 2026, 15:04The Risk Factors and Optimal Prevention Strategies of VTE in Sickle Cell Disease – RPTH Journal